Emerging Trends and Persistent Challenges in Nanomedicines for Rheumatoid Arthritis Therapy

References

1. MadavY. BarveK. PrabhakarB. Current trends in theranostics for rheumatoid arthritis.Eur. J. Pharm. Sci.202014510524010.1016/j.ejps.2020.105240 31987984
   [Google Scholar]
2. ZhengM. JiaH. WangH. Application of nanomaterials in the treatment of rheumatoid arthritis.RSC Adv202111137129713710.1039/D1RA00328C 35423287
   [Google Scholar]
3. LiangW. YuY. LiuZ. The therapeutic potential of targeted nanoparticulate systems to treat rheumatoid arthritis.J. Nanomater.2022202211510.1155/2022/8900658
   [Google Scholar]
4. LeeH. LeeM.Y. BhangS.H. Hyaluronate-gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis.ACS Nano2014854790479810.1021/nn500685h 24730974
   [Google Scholar]
5. AldayelA.M. O’MaryH.L. ValdesS.A. Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate.J. Control. Release201828328028910.1016/j.jconrel.2018.05.035 29859232
   [Google Scholar]
6. DuanW. HuanL. Combination of NF-κB targeted siRNA and methotrexate in a hybrid nanocarrier towards the effective treatment in rheumatoid arthritis.J. Nanobiotechnol20181615810.1186/s12951‑018‑0382‑x
   [Google Scholar]
7. PatraJ.K. DasG. FracetoL.F. Nano based drug delivery systems: Recent developments and future prospects.J. Nanobiotechnol20181617110.1186/s12951‑018‑0392‑8 30231877
   [Google Scholar]
8. WangQ. LiY. ChenX. JiangH. ZhangZ. SunX. Optimized in vivo performance of acid-liable micelles for the treatment of rheumatoid arthritis by one single injection.Nano Res.201912242142810.1007/s12274‑018‑2233‑3
   [Google Scholar]
9. YooJ-W. ChambersE. MitragotriS. Factors that control the circulation time of nanoparticles in blood: Challenges, solutions and future prospects.Solut Fut Prosp2010162122982307 20618151
   [Google Scholar]
10. MitchellM.J. BillingsleyM.M. HaleyR.M. WechslerM.E. PeppasN.A. LangerR. Engineering precision nanoparticles for drug delivery.Nat. Rev. Drug Discov.202120210112410.1038/s41573‑020‑0090‑8 33277608
    [Google Scholar]
11. JoD.H. KimJ.H. LeeT.G. KimJ.H. Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases.Nanomedicine20151171603161110.1016/j.nano.2015.04.015 25989200
    [Google Scholar]
12. LiangH. PengB. DongC. Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation.Nat. Commun.201891429110.1038/s41467‑018‑06603‑5 30327464
    [Google Scholar]
13. WuJ. LiangH. LiY. Cationic block copolymer nanoparticles with tunable DNA affinity for treating rheumatoid arthritis.Adv. Funct. Mater.20203027200039110.1002/adfm.202000391
    [Google Scholar]
14. FangC. ShiB. PeiY.Y. HongM.H. WuJ. ChenH.Z. In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size.Eur. J. Pharm. Sci.2006271273610.1016/j.ejps.2005.08.002 16150582
    [Google Scholar]
15. WangQ. QinX. FangJ. SunX. Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies.Acta Pharm. Sin. B20211151158117410.1016/j.apsb.2021.03.013 34094826
    [Google Scholar]
16. WenJ. LiH. DaiH. Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management.Mater. Today Bio20231910059710.1016/j.mtbio.2023.100597 36910270
    [Google Scholar]
17. DesaiN. Challenges in development of nanoparticle-based therapeutics.AAPS J.201214228229510.1208/s12248‑012‑9339‑4 22407288
    [Google Scholar]
18. FoulkesR. ManE. ThindJ. YeungS. JoyA. HoskinsC. The regulation of nanomaterials and nanomedicines for clinical application: Current and future perspectives.Biomater. Sci.20208174653466410.1039/D0BM00558D 32672255
    [Google Scholar]
19. van der ZeeM. de VriesC. MasaM. MoralesM. RayoM. HeggerI. Regulatory aspects of a nanomaterial for imaging therapeutic cells.Drug Deliv. Transl. Res.202313112693270310.1007/s13346‑023‑01359‑y 37210426
    [Google Scholar]
20. ZhangF. JonssonA.H. NathanA. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes.Nature2023623798761662410.1038/s41586‑023‑06708‑y 37938773
    [Google Scholar]